CoverorDie

Squeeze Report — June 29, 2026

Biotech small-caps dominate today's squeeze radar, with a cluster of high-conviction names like CADL, VERA, and NEO all facing imminent, binary catalysts that could violently punish entrenched shorts. The standout setup is CADL, where heavy insider buying collides with a pivotal BLA submission, while VERA's PDUFA date next week creates a high-stakes, time-compressed pressure cooker.

15 ranked1 hot (≥80)15 squeezable (≥73)

Today's top short-squeeze candidates

  1. #1RZLTRezolute, Inc. Common Stock (N83

    A 54% rally on positive interim data has yet to shake a 20.8% short position betting against the upcoming upLIFT topline readout.

    SI 21%DTC 11.9$5.04+54% 20dHealthcare
  2. #2CADLCandel Therapeutics, Inc. Comm80

    A 30% DFS improvement in Phase 3 and a $3M insider buy set the stage for a squeeze ahead of the Q4 BLA submission.

    SI 30%DTC 7.6$9.79+21% 20dHealthcare
  3. #3LQDALiquidia Corporation Common St79

    YUTREPIA's profitable launch drove a 26% rally, but cheap borrow and heavy insider selling make the 15.9% short interest less urgent.

    SI 16%DTC 7.8$78.17+26% 20dHealthcare
  4. #4GOGrocery Outlet Holding Corp. C79

    A 28% short interest faces a 15% rally and 16 insider buys, but a $180M net loss and goodwill impairment justify bearishness.

    SI 28%DTC 7.7$9.92+15% 20dConsumer Defensive
  5. #5ORICOric Pharmaceuticals, Inc. Com79

    Extreme 17-day-to-cover on low volume creates a coiled spring, but a 0.45% short interest of float undermines the classic squeeze thesis.

    SI 45%DTC 17.2$9.53+13% 20dHealthcare
  6. #6AVTXAvalo Therapeutics, Inc. Commo79

    A Phase 2 catalyst and a 58.9% short interest are offset by a massive follow-on offering that nearly doubled shares outstanding.

    SI 59%DTC 4.4$18.20+13% 20dHealthcare
  7. #7ORKAOruka Therapeutics, Inc. Commo79

    24% of float sold short · 5.0 days to cover · +56% over 20 days

    SI 24%DTC 5.0$90.60+56% 20dHealthcare
  8. #8PTCTPTC Therapeutics, Inc. Common78

    A recent convertible refinancing and buyback could tighten the float just as Sephience ramps up, squeezing a 14.6% short interest.

    SI 15%DTC 11.1$84.43+19% 20dHealthcare
  9. #9VERAVera Therapeutics, Inc. Class78

    With a PDUFA date just days away on July 7, 11 days-to-cover leaves shorts dangerously exposed to a binary outcome.

    SI 19%DTC 11.2$42.46+18% 20dHealthcare
  10. #10WENWendy's Company (The) Common S78

    32% of float sold short · 4.7 days to cover · +4% over 20 days

    SI 32%DTC 4.7$7.80+4% 20dConsumer Cyclical
  11. #11CRVSCorvus Pharmaceuticals, Inc. C77

    24% of float sold short · 8.4 days to cover · +8% over 20 days

    SI 24%DTC 8.4$13.49+8% 20dHealthcare
  12. #12CERTCertara, Inc. Common Stock77

    27% of float sold short · 7.4 days to cover · +3% over 20 days

    SI 27%DTC 7.4$5.84+3% 20dHealthcare
  13. #13MBCMasterBrand, Inc.77

    28% of float sold short · 6.7 days to cover · +9% over 20 days

    SI 28%DTC 6.7$9.88+9% 20dConsumer Cyclical
  14. #14PARPAR Technology Corp.76

    34% of float sold short · 9.2 days to cover · +10% over 20 days

    SI 34%DTC 9.2$16.90+10% 20dTechnology
  15. #15GPGIGPGI, Inc.76

    36% of float sold short · 15.8 days to cover · +26% over 20 days

    SI 36%DTC 15.8$15.06+26% 20dIndustrials

See the full ranked board

This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.

Open the live squeeze board →